GSGPX | MSTVX | GSGPX / MSTVX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 7 years | 6 years | - |
Gain YTD | 2.608 | 1.066 | 245% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.76B | 219M | 2,175% |
Annual Yield % from dividends | 2.62 | 3.78 | 69% |
Returns for 1 year | 9.61 | 6.97 | 138% |
Returns for 3 years | 15.28 | 10.27 | 149% |
Returns for 5 years | 14.01 | 11.69 | 120% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNAX | 70.44 | 0.82 | +1.18% |
Janus Henderson Global Life Sciences A | |||
NCEGX | 21.60 | N/A | N/A |
The North Country Large Cap Equity Fund | |||
RMQHX | 545.45 | N/A | N/A |
Rydex Monthly Rbl NASDAQ-100® 2x Strt H | |||
EEMDX | 7.93 | N/A | N/A |
MFS Emerging Markets Equity Research R1 | |||
GIIZX | 12.05 | N/A | N/A |
GuideStone Funds Intl Eq Idx Investor |